Hologic (HOLX) extends Stephen P. MacMillan’s CEO employment agreement term

Rhea-AI Filing Summary

Hologic, Inc. filed a current report noting a change to its top leadership contract. On September 18, 2025, the company and Stephen P. MacMillan, its Chairman, President and Chief Executive Officer, amended his employment agreement. The amendment solely extends the term of his existing amended and restated agreement dated September 18, 2015, as amended, so that it continues in effect until it is otherwise terminated by either the company or Mr. MacMillan in accordance with its terms. This update maintains continuity in Hologic’s leadership structure without describing any other changes to his role or compensation.

false0000859737DEMA00008597372025-09-182025-09-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) September 18, 2025

HOLOGIC, INC.

(Exact Name of Registrant as Specified in Its Charter)

DELAWARE

(State or Other Jurisdiction of Incorporation)

001-36214		04-2902449
(Commission File Number)		(I.R.S. Employer Identification No.)

250 Campus Drive, Marlborough, Massachusetts		01752
(Address of Principal Executive Offices)		(Zip Code)

(508) 263-2900

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act.

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	HOLX	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 18, 2025, Hologic, Inc. (the “Company”) and Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer, entered into an amendment to Mr. MacMillan’s amended and restated employment agreement dated September 18, 2015, as amended, solely to extend the term of such agreement until such time as the agreement is otherwise terminated by the Company or Mr. MacMillan in accordance with its terms.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 19, 2025	HOLOGIC, INC.
	By:	/s/ Anne M. Liddy
		Anne M. Liddy
		General Counsel

FAQ

What did Hologic (HOLX) change in Stephen P. MacMillan’s employment agreement?

Hologic amended Stephen P. MacMillan’s employment agreement to extend its term so it continues until terminated under its existing terms. The filing describes this as the sole change, without detailing any new responsibilities, compensation changes, or other modifications.

Who is Stephen P. MacMillan in relation to Hologic (HOLX)?

Stephen P. MacMillan serves as Hologic’s Chairman, President and Chief Executive Officer. The 8-K explains that his amended and restated employment agreement, originally dated September 18, 2015, has been further amended to extend its term until terminated by either party under its terms.

When was the amended employment agreement for Hologic’s CEO updated?

The amendment to Stephen P. MacMillan’s employment agreement was entered into on September 18, 2025. The 8-K states this date as the earliest event reported and clarifies that the agreement continues until terminated by Hologic or Mr. MacMillan according to its provisions.

Does the Hologic (HOLX) 8-K mention changes to CEO compensation?

The 8-K only states that the employment agreement with Stephen P. MacMillan was amended solely to extend its term until termination under its terms. It does not describe any changes to salary, incentives, or other compensation arrangements in the disclosed text.

How long will Hologic’s CEO employment agreement remain in effect?

According to the 8-K, Stephen P. MacMillan’s employment agreement will remain in effect until it is terminated by Hologic or Mr. MacMillan in accordance with the agreement’s existing terms. No fixed end date is provided in the described amendment, emphasizing an ongoing arrangement.

What is the significance of the September 18, 2015 date in Hologic’s CEO contract?

The filing explains that Stephen P. MacMillan’s employment agreement was originally an amended and restated agreement dated September 18, 2015, as previously amended. The new amendment references this earlier agreement and simply extends its term rather than replacing its core structure.